Opthea Ltd. ADR (OPT) Social Stream



Opthea Ltd. ADR (OPT): $6.14

-0.46 (-6.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OPT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 481

in industry

Opthea Ltd (OPT) Price Targets From Analysts

Use the tables below to see what analysts covering Opthea Ltd think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-21 4 $50 $25 $39.75 $6.24 537.02%
2021-11-26 2 $50 $25 $37 $6.24 492.95%
2022-03-15 2 $36 $25 $30.5 $6.24 388.78%

Over the past 175 days, OPT's average upside potential has been 461.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-21 1 50 25 39.750 7.360 440.08%
2021-09-21 2 50 36 43.000 7.360 484.24%
2021-09-21 1 50 36 44.666 7.360 506.87%
2021-09-21 1 50 36 43.000 7.360 484.24%
2021-11-26 2 36 25 30.500 7.095 329.88%

OPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Opthea Ltd's upside potential (average analyst target price relative to current price) is higher than 677.93% of all US stocks.
  • In terms of how Opthea Ltd fares relative to all US stocks, note that its number of analysts covering the stock is higher than 57% of that group.
  • In terms of how Opthea Ltd fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 562.73% of that group.
  • In the context of Pharmaceutical Products stocks, Opthea Ltd's variance in analysts' estimates is lower than -140.32% of them.

Stocks similar to Opthea Ltd in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ONVO, OMGA, and OCGN.

Is OPT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5694 seconds.